
Companion Diagnostics: Impact of the COVID-19 Pandemic in Diagnostic Biomarker Market
Advantages of companion diagnostics, the growing need for targeted therapy, the rising importance of personalized medicine, the increasing global incidence of cancer, and the ever-increasing application areas of companion diagnostics are driving the growth of the global companion diagnostics industry. [333 Pages Report] The companion diagnostics market is expected to reach USD 6.8 billion by 2025 from USD 3.7 billion in 2020, at a CAGR of 12.9% … Continue reading Companion Diagnostics: Impact of the COVID-19 Pandemic in Diagnostic Biomarker Market